Claudio D'Addario Selected Research

preproenkephalin

1/2018	Regulation of gene transcription in bipolar disorders: Role of DNA methylation in the relationship between prodynorphin and brain derived neurotrophic factor.
1/2017	Genetic variation and epigenetic modification of the prodynorphin gene in peripheral blood cells in alcoholism.
5/2015	Combined exposure to agriculture pesticides, paraquat and maneb, induces alterations in the N/OFQ-NOPr and PDYN/KOPr systems in rats: Relevance to sporadic Parkinson's disease.
3/2011	Ethanol and acetaldehyde exposure induces specific epigenetic modifications in the prodynorphin gene promoter in a human neuroblastoma cell line.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claudio D'Addario Research Topics

Disease

5	Schizophrenia (Dementia Praecox) 10/2022 - 10/2017
5	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2022 - 01/2019
4	Parkinson Disease (Parkinson's Disease) 12/2020 - 03/2009
4	Alcoholism (Alcohol Abuse) 01/2017 - 01/2008
3	Cognitive Dysfunction 10/2022 - 01/2019
3	Mental Disorders (Mental Disorder) 01/2021 - 01/2020
3	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2020 - 02/2018
3	Bipolar Disorder (Manic Depressive Psychosis) 01/2020 - 06/2012
3	Obesity 12/2019 - 01/2015
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 05/2015
3	Alzheimer Disease (Alzheimer's Disease) 03/2016 - 01/2012
2	Anxiety Disorders (Anxiety Disorder) 01/2021 - 08/2020
2	Inflammation (Inflammations) 08/2020 - 01/2019
2	Bulimia (Binge Eating) 12/2019 - 01/2019
2	Neoplasms (Cancer) 01/2019 - 03/2015
2	Psychotic Disorders (Schizoaffective Disorder) 10/2017 - 06/2012
2	Neuroblastoma 03/2011 - 03/2008
1	Wounds and Injuries (Trauma) 01/2022
1	Body Weight (Weight, Body) 01/2021
1	Atopic Dermatitis (Atopic Eczema) 01/2021
1	Dyskinesias (Dyskinesia) 12/2020
1	Anorexia Nervosa 01/2020
1	Neurobehavioral Manifestations 01/2020
1	Iron Overload 01/2019
1	Atherosclerosis 01/2019
1	Gambling (Pathological Gambling) 01/2017
1	Frontotemporal Dementia (Semantic Dementia) 03/2016
1	Colonic Neoplasms (Colon Cancer) 03/2015
1	Colorectal Neoplasms (Colorectal Cancer) 03/2015
1	Overweight 01/2015
1	Weight Gain 01/2015
1	Mood Disorders (Mood Disorder) 09/2014
1	Dementia (Dementias) 01/2014
1	Disease Progression 01/2014
1	Skin Diseases (Skin Disease) 10/2013
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 06/2013
1	Major Depressive Disorder (Major Depressive Disorders) 01/2013
1	Nervous System Diseases (Neurological Disorders) 01/2012

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2014
7	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2022 - 06/2012
7	Opioid Analgesics (Opioids)IBA 01/2019 - 03/2008
6	EndocannabinoidsIBA 10/2022 - 03/2015
5	Messenger RNA (mRNA)IBA 01/2021 - 11/2002
5	CannabidiolIBA 01/2021 - 10/2013
4	NeuropeptidesIBA 08/2020 - 11/2002
4	preproenkephalinIBA 01/2018 - 03/2011
4	NociceptinIBA 05/2015 - 11/2002
3	Methylazoxymethanol AcetateIBA 10/2022 - 01/2019
3	Biological ProductsIBA 01/2022 - 01/2019
3	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 01/2020
3	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2020 - 01/2017
3	Ethanol (Ethyl Alcohol)IBA 01/2017 - 01/2008
2	Antimitotic AgentsIBA 10/2022 - 01/2019
2	AM 251 (AM251)IBA 10/2022 - 01/2019
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2021 - 01/2019
2	CannabinoidsIBA 01/2021 - 01/2019
2	Serotonin (5 Hydroxytryptamine)IBA 01/2021 - 01/2017
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2020 - 01/2019
2	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 12/2019 - 01/2019
2	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 01/2019 - 01/2012
2	Dynorphins (Dynorphin)IBA 01/2017 - 05/2013
2	AcetaldehydeIBA 03/2011 - 03/2008
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Oxytocin Receptors (Oxytocin Receptor)IBA 01/2022
1	Methyl-CpG-Binding Protein 2IBA 01/2022
1	PolyphenolsIBA 01/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 08/2020
1	Nerve Growth Factors (Neurotrophins)IBA 08/2020
1	Dopamine D3 ReceptorsIBA 01/2020
1	Neutralizing AntibodiesIBA 01/2020
1	Antipsychotic Agents (Antipsychotics)IBA 01/2020
1	FlavonoidsIBA 12/2019
1	proanthocyanidinIBA 12/2019
1	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2019
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 12/2019
1	Lysine (L-Lysine)FDA Link 01/2019
1	Histones (Histone)IBA 01/2019
1	IronIBA 01/2019
1	Haloperidol (Haldol)FDA LinkGeneric 01/2019
1	5' Untranslated Regions (5' UTR)IBA 02/2018
1	methylazoxymethanolIBA 10/2017
1	Acetates (Acetic Acid Esters)FDA Link 10/2017
1	Proteins (Proteins, Gene)FDA Link 03/2016
1	Agrochemicals (Agricultural Chemicals)IBA 05/2015
1	Environmental Pollutants (Pollutants, Environmental)IBA 05/2015
1	ParaquatIBA 05/2015
1	ManebIBA 05/2015
1	Olive OilIBA 03/2015
1	LipidsIBA 03/2015
1	Peptides (Polypeptides)IBA 01/2015
1	ProgranulinsIBA 06/2013
1	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 01/2013
1	LipoxygenasesIBA 01/2013
1	gamma-Aminobutyric Acid (GABA)IBA 03/2009
1	Glutamic Acid (Glutamate)FDA Link 03/2009
1	Naltrexone (ReVia)FDA LinkGeneric 01/2008
1	Opioid Receptors (Opioid Receptor)IBA 01/2008

Therapy/Procedure

4	Therapeutics 01/2020 - 01/2012
1	Mediterranean Diet 03/2015
1	Drug Therapy (Chemotherapy) 01/2008